FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
This article was originally published in The Gray Sheet
Executive Summary
The House Energy & Commerce Committee will review FDA's conflict-of-interest procedures as part of an expanding probe that originally focused on National Institutes of Health employee consulting arrangements
You may also be interested in...
House Loses Medical Device Reform Architect To BIO
Rep. Jim Greenwood's (R-Penn.) experience drafting combination product legislation suggests BIO will be alert to shared opportunities in the biologics/device policy arena
House Loses Medical Device Reform Architect To BIO
Rep. Jim Greenwood's (R-Penn.) experience drafting combination product legislation suggests BIO will be alert to shared opportunities in the biologics/device policy arena
FDA Ethics Under Spotlight Of House Oversight Subcommittee Investigation
The House Energy & Commerce/Oversight & Investigations Subcommittee is shifting its ongoing ethics investigation toward FDA, Rep. Joe Barton (R-Texas) said May 18 at an NIH ethics hearing